title: Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA.
abstract: A key goal of our recent research efforts has been to develop novel 'triggerable nanoparticle' systems with real potential utility in vivo. These are designed to be stable from the point of administration until a target site of interest is reached, then triggered for the controlled release of therapeutic agent payload(s) at the target site by changes in local endogenous conditions or through the application of some exogenous stimulus. Here we describe investigations into the use of enzymes to trigger RNAi-mediated therapy through a process of enzyme-assisted nanoparticle triggerability. Our approach is to use PEG(2000)-peptidyl lipids with peptidyl moieties sensitive to tumour-localized elastase or matrix metalloproteinase-2 digestion, and from these prepare putative enzyme-triggered PEGylated siRNA-nanoparticles. Our results provide initial proof of concept in vitro. From these data, we propose that this concept should be applicable for functional delivery of therapeutic nucleic acids to tumour cells in vivo, although the mechanism for enzyme-assisted nanoparticle triggerability remains to be fully characterized.
authors.affiliation: Imperial College Genetic Therapies Centre, Department of Chemistry, Imperial College London, London, SW7 2AZ, UK.
authors.forename: Peerada
authors.initials: P
authors.lastname: Yingyuad
authors.affiliation: Imperial College Genetic Therapies Centre, Department of Chemistry, Imperial College London, London, SW7 2AZ, UK.
authors.forename: Mathieu
authors.initials: M
authors.lastname: Mével
authors.affiliation: Imperial College Genetic Therapies Centre, Department of Chemistry, Imperial College London, London, SW7 2AZ, UK.
authors.forename: Carla
authors.initials: C
authors.lastname: Prata
authors.affiliation: Imperial College Genetic Therapies Centre, Department of Chemistry, Imperial College London, London, SW7 2AZ, UK ; Institute of Pharmaceutical Science, Franklin-Wilkins Building, 150 Stamford Street, King's College London, London, SE1 9NH, UK.
authors.forename: Christos
authors.initials: C
authors.lastname: Kontogiorgis
authors.affiliation: Imperial College Genetic Therapies Centre, Department of Chemistry, Imperial College London, London, SW7 2AZ, UK ; Institute of Pharmaceutical Science, Franklin-Wilkins Building, 150 Stamford Street, King's College London, London, SE1 9NH, UK.
authors.forename: Maya
authors.initials: M
authors.lastname: Thanou
authors.affiliation: Imperial College Genetic Therapies Centre, Department of Chemistry, Imperial College London, London, SW7 2AZ, UK ; Institute of Pharmaceutical Science, Franklin-Wilkins Building, 150 Stamford Street, King's College London, London, SE1 9NH, UK.
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Miller
keywords: Liposomes; elastase; enzyme; peptide; triggerable nanoparticles; triggered release
references.citation: Bioconjug Chem. 2008 Jan;19(1):118-29
references.pmid: 17985841
references.citation: Bioconjug Chem. 2009 Apr;20(4):648-55
references.pmid: 19368341
references.citation: Gene Ther. 2008 Dec;15(24):1593-605
references.pmid: 18633447
references.citation: J Control Release. 2006 Apr 10;111(3):333-42
references.pmid: 16488046
references.citation: J Control Release. 2010 Apr 19;143(2):222-32
references.pmid: 19969034
references.citation: Exp Biol Med (Maywood). 2008 Aug;233(8):1013-20
references.pmid: 18480415
references.citation: J Control Release. 2011 Sep 25;154(3):275-84
references.pmid: 21699935
references.citation: Int J Cancer. 2005 Mar 10;114(1):19-31
references.pmid: 15523695
references.citation: Chem Soc Rev. 2005 Nov;34(11):970-94
references.pmid: 16239997
references.citation: Angew Chem Int Ed Engl. 2006 May 5;45(19):3161-5
references.pmid: 16642514
references.citation: Proc Natl Acad Sci U S A. 2002 May 28;99(11):7414-9
references.pmid: 12032297
references.citation: Biochim Biophys Acta. 1999 Jul 15;1419(2):111-26
references.pmid: 10407064
references.citation: Chembiochem. 2005 Jul;6(7):1212-23
references.pmid: 15937988
references.citation: J Cell Sci. 2009 Nov 15;122(Pt 22):4089-98
references.pmid: 19910495
references.citation: BMC Cell Biol. 2010 Jul 05;11:51
references.pmid: 20602761
references.citation: Tumori. 2008 Mar-Apr;94(2):234-45
references.pmid: 18564612
references.citation: Gene Ther. 2007 Jan;14(1):68-77
references.pmid: 16915290
references.citation: Biochim Biophys Acta. 1998 Jun 24;1372(1):13-27
references.pmid: 9651469
references.citation: Org Biomol Chem. 2010 Jan 7;8(1):201-11
references.pmid: 20024151
references.citation: J Surg Res. 2010 Mar;159(1):443-50
references.pmid: 20031158
references.citation: Cancer Res. 1994 Jul 1;54(13):3611-6
references.pmid: 8012988
references.citation: Bioconjug Chem. 2013 Mar 20;24(3):343-62
references.pmid: 23305338
references.citation: Mol Pharm. 2009 May-Jun;6(3):706-17
references.pmid: 19159285
references.citation: J Control Release. 2011 Jan 20;149(2):111-6
references.pmid: 20888381
references.citation: Bioconjug Chem. 2013 Mar 20;24(3):314-32
references.pmid: 23305315
references.citation: Mol Pharm. 2010 Dec 6;7(6):2040-55
references.pmid: 20929266
references.citation: Biopolymers. 1991 Nov;31(13):1471-81
references.pmid: 1814499
references.citation: Langmuir. 2009 May 5;25(9):4886-91
references.pmid: 19341292
references.citation: Clin Exp Metastasis. 2000;18(6):493-9
references.pmid: 11592306
references.citation: Biochemistry. 2003 May 27;42(20):6067-77
references.pmid: 12755608
references.citation: J Microbiol Biotechnol. 2009 Aug;19(8):781-6
references.pmid: 19734715